MAIN ALAN J
SEC insider (Form 3/4/5 filer). CIK 0001227372. EVP, Innov & Chem Sciences at LEXICON PHARMACEUTICALS, INC. (LXRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 28, 2025. Located in THE WOODLANDS, TX.
Companies MAIN ALAN J has filed insider reports for
- LEXICON PHARMACEUTICALS, INC. (LXRX): Officer, EVP, Innov & Chem Sciences
MAIN ALAN J
CIK: 0001227372
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXICON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect25.7K shares- - Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect32.9K shares- - Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect68.2K shares- - Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
Tax PaymentDirect43.4K shares at avg. $0.67$29K - Feb 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
753.1K shares- - Feb 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
502.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 25,667 | - | - | Direct |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 32,904 | - | - | Direct |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 68,243 | - | - | Direct |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Tax Payment | 43,434 | $0.67 | $29,101 | Direct |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 753,090 | - | - | Direct |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 502,060 | - | - | Direct |
1-6 of 6 transactions